Market Size, Demand & Growth

The economics of a dialysis center are unusual: demand is almost perfectly inelastic. A person with end-stage kidney disease (ESKD) needs roughly three treatments a week to stay alive, every week, indefinitely. That is what makes the revenue base so predictable, and what makes the regulatory and reimbursement detail the part of the plan that actually decides whether you make money.

The US dialysis centers market was valued at $29.51 billion in 2024 and is forecast to grow at a 5.4% compound annual rate through 2030 (Grand View Research, 2024). A separate read from GM Insights, 2025 puts the US dialysis services market at $31.14 billion in 2025, reaching $52.2 billion by 2034. Globally, IMARC Group, 2025 sizes the dialysis market at $125.8 billion, climbing toward $181.2 billion by 2034.

The demand driver behind those numbers is patient volume. More than 808,000 Americans live with ESKD, and roughly 68% of them depend on dialysis rather than a transplant (CMS / National Kidney Foundation). Diabetes and hypertension, the two leading causes of kidney failure, continue to rise, which is why analysts treat the patient base as a long-duration growth curve rather than a cyclical one.

Two companies dominate the chair count. Fresenius Medical Care runs roughly 2,600-2,800 US centers (about 38% of the market) and DaVita runs about 2,657 (around 37%). The remaining quarter is split between independents and regional operators such as U.S. Renal Care, the non-profit Dialysis Clinic Inc (DCI), and California's Satellite Healthcare. That concentration is the single most important fact for a new entrant: you are not trying to out-scale Fresenius. You win by locating in an access gap the majors have not bothered to fill, and most independent business plans that secure funding are built around that geographic argument.

In the UK and across most of Europe, dialysis sits largely inside public health systems, so the commercial opportunity is narrower and usually takes the form of an NHS-contracted independent unit or a satellite of a larger renal network. We cover the UK licensing route in detail below, because the model, and the money, work very differently from the US payer-mix story.

Who the Center Actually Serves

The patient is the obvious customer, but the buying decision in dialysis is shared, and a strong market section names every party that influences where a patient ends up dialysing. Patients themselves choose on travel distance, chair availability at convenient shift times, and the reputation of the clinical team. Nephrologists drive a large share of referrals, so a relationship with the local renal physician group is often worth more than any marketing spend. Hospital discharge planners and case managers route newly-diagnosed ESKD patients to a center as they transition off acute inpatient dialysis. And payers, Medicare, state Medicaid programmes, and commercial insurers, set the rules that determine which of those patients are economically viable to serve.

A credible plan segments this carefully. The primary segment is the in-center hemodialysis patient who needs three sessions a week within a reasonable drive. The secondary segment is the home-dialysis candidate, peritoneal or home hemodialysis, who needs training and recurring supplies rather than a chair. The expansion segment is the value-based-care population reached through risk-bearing contracts, where a center is paid partly on outcomes rather than purely on volume. Each segment has a different cost-to-serve and a different margin, and the plan should make clear which one the center is built around first.

Where an Independent Can Actually Win

You will not out-scale Fresenius or DaVita on procurement or brand, so the competitive section has to be honest about where the gap is. In practice independents win on three fronts. The first is geography: an underserved town or a growing suburb where the majors have not yet placed a center, often because the projected census sat just below their internal threshold. The second is responsiveness, shorter wait times for a chair, more flexible shift scheduling, and a clinical team patients actually recognise. The third is a home-dialysis programme built deliberately rather than treated as an afterthought, which both improves patient outcomes and opens a recurring revenue line the big operators sometimes under-serve locally. The plan should map the nearest competing centers, their approximate chair counts, and the specific access gap the new center fills.

Questions Founders Ask First

These are the questions that come up before anyone writes a word of the plan. Short answers here; the detailed numbers live in the sections that follow.

How many patients can a dialysis center treat per day?

Capacity is a function of stations and shifts, not floor space. A station can run three shifts a day, and each patient occupies a chair for about four hours plus turnaround. A 20-station center running three shifts can serve roughly 60 patient-treatments per day; because most patients dialyse three times a week, that supports a steady-state census of around 120 patients. Most plans model 6 days a week (Monday-Saturday), which is why station count, not building size, is the real ceiling on revenue.

Do you need a Certificate of Need to open a dialysis center?

In about 35 US states, yes. A Certificate of Need (CON) is a state approval proving the area needs more dialysis capacity before you can build. In CON states the process can add 6-18 months and is openly contested by incumbents. In CON-free states, Texas, Arizona, and Oklahoma among them, you skip that gate entirely, which is why state selection often does more to set your timeline than any other single decision in the plan.

What is the Medicare reimbursement rate for dialysis treatments?

Medicare pays through the ESRD Prospective Payment System (PPS) as a single bundled rate per treatment. The CY 2026 base rate is $281.71 per treatment, up from $273.82 in 2025. That bundle covers the treatment, most drugs, and routine lab work, you cannot bill those separately. Commercial insurers typically pay 3-4x that rate, which is why payer mix dominates the financial model.

How long does CMS ESRD certification take?

After you enrol with your Medicare Administrative Contractor and pass a state survey, expect a roughly 90-day initial survey window, with total enrolment running 90-180 days. You cannot bill Medicare, which for most centers is the majority of revenue, until certification is granted, so this timeline sits on the critical path of every credible plan.

What It Costs to Open a Center

A kidney dialysis center is a capital-heavy build, not a service startup. A realistic all-in range for a US outpatient ESRD facility is $975,000 to $4 million (roughly £800,000 to £3.2 million), driven by the medical-grade build-out, the machines, and the water treatment plant that sits behind them. The spread is wide because a 12-station unit in a low-cost state and a 24-station flagship in a metro market are genuinely different projects.

Where the Capital Goes

• Facility build-out & medical renovation (specialised plumbing, HVAC, utility rooms): $500K-$1.5M / £400K-£1.2M
• Hemodialysis machines (12-20 stations at $20K-$35K each): $240K-$700K / £190K-£560K
• Water purification system (reverse-osmosis, AAMI-compliant): $100K-$300K / £80K-£240K
• State licensing, CMS ESRD certification & CON filing: $50K-$100K / £15K-£40K (CQC registration in the UK)
• Pre-opening staffing & training (nephrologist, nurses, technicians): $100K-$250K / £80K-£200K
• EHR & patient management software: $30K-$80K / £25K-£65K
• Working capital (3-6 months; billing cycles run 60-90 days): $150K-$300K / £120K-£240K
• Professional indemnity & medical malpractice insurance: $25K-$60K/yr / £20K-£50K/yr

The line item first-time operators consistently misjudge is working capital. Dialysis is reimbursed in arrears, and Medicare claims often take 60-90 days to pay. You will be paying nephrologist and nursing salaries, leasing payments, and consumables for two to three months before the first meaningful cash lands. A plan that funds the build but not the cash-flow gap is a plan that runs out of money in month four.

Funding Routes

US operators typically stack three sources: an SBA 7(a) loan (up to $5M, terms to 25 years for real estate), personal or physician-partner equity, and equipment financing where the machines themselves serve as collateral. Because the build is expensive, many independents bring a nephrologist in as an equity partner, both for the capital and because medical-director continuity strengthens the certification application. In the UK, financing usually runs through commercial healthcare lenders or NHS contract-backed facilities rather than a single startup-loan scheme. Our bespoke business plan service builds the lender-ready financial pack, five-year projections, payer-mix sensitivity, and break-even, that healthcare underwriters expect to see.

Equipment & Water Treatment Checklist

Dialysis equipment is regulated medical hardware, and the water plant behind it is as important as the chairs. Patients are exposed to 300-600 litres of water per treatment across a thin membrane, so water purity is a clinical safety issue governed by AAMI standards in the US and BS EN ISO 23500 in the UK. Here is the core capital equipment list a credible operations plan needs to specify.

• Hemodialysis machines, Fresenius 2008T / 5008S or B. Braun Dialog+ units, $20K-$35K per station
• Reverse-osmosis water treatment plant, central RO with pre-treatment (carbon filtration, water softener, dechlorination), $100K-$300K
• Water distribution loop, medical-grade PEX/PVDF piping with heat or chemical disinfection capability
• Dialysis chairs / treatment recliners, one per station, $2K-$5K each
• Reprocessing equipment, if reusing dialyzers, automated reprocessors (many US centers now run single-use)
• Crash cart & emergency kit, defibrillator, oxygen, emergency medications per CMS conditions for coverage
• EHR / patient-management software, renal-specific systems such as Proton (Dialysis), CrownWeb-reporting tools, and revenue-cycle billing
• Cold-chain refrigeration, for erythropoiesis-stimulating agents and other bundled drugs
• Water-quality testing equipment, endotoxin and chemical contaminant testing for quarterly AAMI/ISO compliance

One planning note worth flagging: the water system is not a plumbing line item. Budget it as the clinical-grade installation it is, including validation testing before opening and a recurring quarterly testing programme. Centers that treat it as renovation cost almost always under-fund it and then face a delayed certification survey.

Staffing & Clinical Ratios

Staffing is the largest operating cost in a dialysis center, typically 55-60% of revenue, so the staffing model deserves as much rigour in the plan as the equipment list. Under CMS conditions for coverage, a patient-care technician generally supervises no more than three to four patients during treatment, and a registered nurse oversees the floor and handles assessments, medication, and any complications. The plan should model these ratios at target census across every shift, because the ratio, not the chair count, often sets the real labour budget.

• Medical director, a board-certified nephrologist, required for CMS certification; often a part-time contracted role for an independent
• Charge / registered nurses, floor supervision, patient assessment, vascular access management, and emergency response
• Patient-care technicians, direct treatment delivery, roughly one per three to four patients per shift
• Renal dietitian and social worker, required members of the interdisciplinary care team under the conditions for coverage
• Biomedical technician, machine maintenance and water-system monitoring, in-house or contracted
• Administrative and billing staff, scheduling, payer enrollment, and the revenue cycle that turns treatments into cash

A subtle scheduling point shapes the labour line: because most patients dialyse on a Monday-Wednesday-Friday or Tuesday-Thursday-Saturday rota, staffing has to flex across a six-day week rather than a standard five. Plans that budget a flat weekday headcount usually understate both payroll and the recruitment runway needed to fill specialist clinical roles in a tight nephrology labour market.

Reimbursement & Unit Economics

Almost everything about dialysis profitability comes down to one variable most generic plans gloss over: your payer mix. Medicare and commercial insurers pay for the identical treatment at wildly different rates, and the proportion of each in your patient census decides whether your margin is 8% or 20%.

Medicare pays through the ESRD PPS bundle, a fixed $281.71 per treatment in CY 2026 (base rate; $273.82 in 2025). On an annual basis that works out to roughly $35,424 per Medicare patient per year. Commercial insurers, by contrast, frequently reimburse 3-4x more, close to $148,722 per commercially-insured patient per year on comparable treatment counts. The arithmetic consequence is stark: a patient population that is only 12% commercially insured can still produce around 40% of total revenue. Get the payer-mix forecast wrong and the whole financial model is wrong.

Worked Example: A 20-Station Center

Take a 20-station center treating 100 patients, three sessions a week. That is roughly 156 treatments per patient per year. At the blended Medicare rate, 100 patients generate about $4.39 million in gross revenue. Layer in a 15% commercial mix at ~$500 per session and you add roughly $468,000, for total revenue near $4.86 million. After staffing (typically 55-60% of revenue), facility overhead, consumables, and billing costs, net operating margin lands in the 14-18% band, the upper end only if the commercial mix and station utilisation both hold.

Revenue Streams to Model

• Medicare / Medicaid ESRD PPS bundle, $281.71 base per treatment (2026); the volume floor of the business
• Commercial insurance reimbursement, 3-4x Medicare; the margin engine
• Home / peritoneal dialysis programmes, lower facility cost, recurring supply and training revenue
• Peritoneal dialysis supply sales and training fees
• In-center ancillary services, nutritional counselling and social-work case management
• Value-based care contracts, e.g. the ESRD Treatment Choices (ETC) Model

The strategic point your plan should make is that revenue stability comes from Medicare volume, but profitability comes from commercial mix and from a home-dialysis programme that many independents under-build. Modelling all of that is what separates a fundable plan from a hopeful one.

The 30-Month Commercial Window

There is a reimbursement nuance that materially changes the early-year forecast: when a patient first becomes eligible for Medicare due to ESKD, there is a coordination period, currently 30 months, during which an employer group health plan pays as the primary insurer before Medicare takes over. For patients who arrive with commercial coverage, that window is a stretch of higher-rate reimbursement, and a center that ramps its census with a healthy share of commercially-insured, recently-diagnosed patients earns materially more in years one and two than a Medicare-heavy ramp implies. A forecast that ignores this coordination period tends to understate early revenue and then look surprised when cash arrives faster than modelled. The plan should show the assumed share of patients inside that window and how it tapers as those patients transition to Medicare-primary.

Bad debt and contractual adjustments also belong in the model. Gross charges and collected revenue are not the same number in healthcare; commercial contracts carry negotiated discounts, and a slice of patient-responsibility balances never collects. A conservative plan books revenue net of expected contractual adjustments and a bad-debt allowance, rather than presenting gross charges as though they all convert to cash.

SBA & Healthcare Lending Data

Dialysis centers fall under NAICS 621492, Kidney Dialysis Centers. Under the SBA's size standard, a business in this code is "small" if its average annual receipts are under $47 million, so virtually every independent startup qualifies for SBA-backed financing.

• NAICS code: 621492 (Kidney Dialysis Centers), confirm this on every SBA and lender form
• SBA size standard: $47M average annual receipts, independents qualify comfortably
• SBA 7(a) ceiling: up to $5M; commonly used for build-out, equipment, and working capital combined
• SBA 504: a strong fit when you are purchasing or constructing the real estate, splitting the loan across a CDC and a bank
• Terms: up to 25 years for real estate, up to 10 years for equipment and working capital
• Collateral: machines and the water plant are financeable assets; physician-partner equity strengthens the application

Two practical notes for the funding section. First, healthcare lenders weigh the medical director and clinical-leadership team heavily, an SBA package for a dialysis center is judged on operating credibility, not just the spreadsheet. Second, because the certification timeline pushes first revenue out 6-9 months, underwriters want to see a working-capital cushion that explicitly covers the pre-revenue period. Our research and content package assembles the NAICS-matched lending narrative and the projections lenders ask for.

A few documents tend to make or break the lending conversation, so build them into the plan rather than scrambling for them later. Lenders for a center this capital-intensive typically want to see a signed or draft medical-director agreement, a letter of intent or lease for the premises, vendor quotes for the machines and water system that substantiate the capital request, and a payer-mix-driven five-year forecast with clearly stated assumptions. They will also look for the founder's relevant clinical or operating experience and a personal financial statement, since SBA loans require a personal guarantee. The stronger the operating evidence, the more comfortable an underwriter is with the long pre-revenue runway that defines this business.

Licensing, CON & Certification

Dialysis is one of the most heavily regulated outpatient businesses you can open. The licensing layer is where timelines balloon and where first-time operators most often underestimate the work. Here is the requirement set by jurisdiction.

United States

• CMS ESRD Certification (42 CFR Part 494), Centers for Medicare & Medicaid Services; ~$50K-$100K in preparation and fees; a ~90-day initial survey after MAC application approval. This is the gate to Medicare billing.
• Certificate of Need (CON), State Health Department; $5K-$50K in filing and review; 6-18 months in CON-required states. Required in roughly 35 states.
• State Dialysis Facility License, state health licensing board (e.g. CDPH in California); $1K-$10K; 3-6 months.
• CLIA Certification (for in-house lab), CMS CLIA Program; $1,500-$3,000 annual fee; 60-90 days.
• Medicare Provider Enrollment (Form CMS-855A), via your Medicare Administrative Contractor; no fee but ~$10K-$30K in staff/legal time; 90-180 days.
• DEA Registration (if dispensing controlled substances), $888 per 3-year period; 4-6 weeks.

United Kingdom

• CQC Registration (independent dialysis unit), Care Quality Commission; £1,648-£9,028 annually by income band; 3-6 months with a full inspection.
• NHS Provider Licence (for NHS-contracted services), NHS England; no direct fee but substantial compliance cost; 3-9 months.
• Data Security & Protection (DSP) Toolkit, NHS Digital; annual certification; ongoing.
• Water quality compliance (BS EN ISO 23500), local authority plus internal audit; £10K-£30K for validation and quarterly testing.
• Employers' liability insurance (£5M+ mandatory), FCA-regulated insurer; £8K-£25K/yr.

Australia & Canada

• Australia: AHPRA registration for clinical staff; Therapeutic Goods Administration (TGA) approval for dialysis devices; a state health department facility licence; NDIS provider registration where applicable.
• Canada: a provincial Ministry of Health facility licence; provincial College of Physicians registration; Health Canada approval for dialysis equipment.

The cross-cutting lesson: in the US the CON and CMS certification timelines are the binding constraint, and in the UK the CQC inspection is. Either way, you cannot bill the payer that funds most of your revenue until the relevant approval is granted, so the licensing schedule belongs at the centre of your launch plan, not in an appendix.

Mistakes That Sink First-Time Operators

These are the errors we see most often in dialysis plans that fail to fund, or in centers that fund and then struggle. Each one is avoidable with the right forecast detail.

• Underestimating the CON timeline. Some states require 12-18 months of regulatory approval before construction can even begin. Building a launch schedule that assumes a few months is how a plan loses credibility with lenders who know the sector.
• Modelling revenue on Medicare rates only. The minority of patients with commercial insurance can generate around 40% of total revenue. A model that ignores payer mix understates both revenue and risk.
• Treating water infrastructure as "plumbing." AAMI-compliant RO water systems run $100K-$300K and need quarterly testing. Under-budgeting here delays the certification survey and the first Medicare dollar.
• Staffing before certification. Hiring nephrologists and nurses before CMS certification is complete can burn $50K-$100K in pre-revenue payroll. Sequence hiring against the survey timeline.
• Under-building the home-dialysis programme. Peritoneal and home hemodialysis carry lower facility cost but strong recurring supply and training revenue, income many plans simply leave on the table.

Sample Business Plan Preview

Here's an extract from a dialysis-center plan in the format our team produces, so you can see the level of operational and financial detail you'll be working from:

What's Inside the Template

The Avvale kidney dialysis center template is pre-structured for the way this business is actually evaluated by lenders and CMS reviewers, not a generic outline with the industry name dropped in:

• Executive Summary, station count, target census, payer-mix thesis, and funding ask in one page
• Company & Clinical Overview, ownership, medical director, and clinical-governance structure
• Market & Access Analysis, local ESKD prevalence, competitor center mapping, and the access-gap argument
• Regulatory & Certification Roadmap, CON status, CMS ESRD survey timeline, and state licensing milestones
• Operations Plan, shift scheduling, station utilisation, water-treatment programme, and staffing ratios
• Payer-Mix & Reimbursement Model, Medicare PPS bundle vs commercial assumptions, with sensitivity ranges
• Financial Forecast Structure, five-year revenue build, working-capital schedule, and break-even analysis
• Risk & Compliance, staffing, water quality, billing, and survey-readiness controls

The Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a five-year Excel model with income statement, cash flow, balance sheet, payer-mix sensitivity, break-even, and a startup-capital schedule that explicitly funds the pre-certification cash gap. For closely related models, see our free business plan templates hub and the business plan writer service, or browse adjacent healthcare templates such as the clinical diagnostics business plan template.

Frequently Asked Questions